Verapamil attenuates the malignant treatment course in recurrent status epilepticus

被引：33

作者：

Schmitt, Friedhelm C. ^{[1
,2
]}

Dehnicke, Christoph ^{[2
]}

Merschhemke, Martin ^{[2
]}

Meencke, Heinz-Joachim ^{[2
]}

机构：

[1] Otto Von Guericke Univ, Univ Hosp Neurol, D-39120 Magdeburg, Germany

[2] Humboldt Univ, Teaching Hosp, Epilepsy Ctr Berlin Brandenburg, Ev Krankenhaus Konigin Elisabeth Herzberg, Berlin, Germany

来源：

EPILEPSY & BEHAVIOR | 2010年 / 17卷 / 04期

关键词：

Malignant; Multidrug transporter; Pharmacoresistance; P-glycoprotein; Refractory; Recurrent; Status epilepticus; Verapamil; REFRACTORY STATUS EPILEPTICUS; ANTIEPILEPTIC DRUGS; P-GLYCOPROTEIN; EPILEPSY; ANTAGONISTS; MODULATION; BLOCKERS; SEIZURE;

D O I：

10.1016/j.yebeh.2010.01.166

中图分类号：

B84 [心理学]; C [社会科学总论]; Q98 [人类学];

学科分类号：

03 ; 0303 ; 030303 ; 04 ; 0402 ;

摘要：

In the scenario of refractory status epilepticus, the recommended approach of intensive care treatment is limited with respect to the available pharmacodynamic variability and its impeding, severe side effects. Alternative treatment options are therefore urgently needed. In the case described, a patient with nonlesional frontal lobe epilepsy had a high-frequency series of tonic seizures, which evolved into a malignant form of status epilepticus. Co-administration of verapamil, a potent multidrug transporter inhibitor, was followed by significant reduction in seizure frequency. We discuss the putative role of verapamil and the specific risk factors for this malignant treatment course. (C) 2010 Elsevier Inc. All rights reserved.

引用

页码：565 / 568

页数：4

共 25 条

[1] NO EVIDENCE FOR EFFICACY OF INTRATHECAL VERAPAMIL IN THE TREATMENT OF TONIC-CLONIC STATUS EPILEPTICUS [J].